+
Site Tour

Tri.Fr 2 years outcomes presented at ACC 2026

The Tri.Fr trial delivered sustainable evidence . Together with the Triluminate Pivotal trial , the results confirm TriClip TEER as the only TTVI therapy with consistent evidence demonstrating both symptomatic improvement and reduction in HFH

Download

LEARN MORE:

TriClip Clinical Data

Related Resources

Navitor 5-years data from CRT

Tendyne expanded clinical study | PCR LV 2025

EXPAND G4 clinical data release | PCR LV 2025

bRIGHT clinical data release | PCR LV 2025

Navitor Active-Sealing Cuff

Navitor Low PPI & Radiopaque Markers

The standard of caring for TR

TRENDING TOPICS

Navitor 5-years data from CRT

Discover Navitor IDE 5-years outcomes

bRIGHT clinical data release | PCR LV 2025

bRIGHT procedural clipping strategy presented at PCR LV 2025 by X. Freixa

EXPAND G4 clinical data release | PCR LV 2025

2-year outcomes from the EXPAND G4 study presented at PCR LV 2025 by F. De Marco

CONNEXT


TV
RELATED RESOURCES

New clinical evidence and patient selection M-TEER therapy

Artifical intelligence in structural heart imaging

Anatomy for structural heart therapies

Why Amulet™ LAAO: An Experts Opinion

CONNEXT


LIVE
RELATED EVENTS

New clinical evidence and patient selection M-TEER therapy

Artifical intelligence in structural heart imaging

Anatomy for structural heart therapies

Transcatheter Aortic Valves Implant - 2025

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline